1,959 hedge funds and large institutions have $144B invested in Pfizer in 2016 Q3 according to their latest regulatory filings, with 75 funds opening new positions, 885 increasing their positions, 762 reducing their positions, and 81 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership:

less call options, than puts

Call options by funds: $ | Put options by funds: $

less first-time investments, than exits

New positions opened: | Existing positions closed:

1% less funds holding

Funds holding: 1,9881,959 (-29)

5% less capital invested

Capital invested by funds: $152B → $144B (-$8.2B)

18% less funds holding in top 10

Funds holding in top 10: 286234 (-52)

Holders
1,959
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
234
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.25B
Puts
$2.33B
Net Calls
Net Calls Change

Top Buyers

1 +$351M
2 +$340M
3 +$281M
4
Renaissance Technologies
Renaissance Technologies
New York
+$240M
5
JP Morgan Chase
JP Morgan Chase
New York
+$183M
Name Holding Trade Value Shares
Change
Change in
Stake
1351
$1.13M
1352
$1.13M
1353
$1.13M
1354
$1.13M
1355
$1.12M
1356
$1.12M
1357
$1.11M
1358
$1.11M
1359
$1.11M
1360
$1.11M
1361
$1.11M
1362
$1.1M
1363
$1.1M
1364
$1.1M
1365
$1.09M
1366
$1.09M
1367
$1.09M
1368
$1.09M
1369
$1.09M
1370
$1.08M
1371
$1.08M
1372
$1.08M
1373
$1.07M
1374
$1.07M
1375
$1.07M